Pharma giants pay millions to Russian distributor entangled in corruption allegations to win cancer drug business
Whistleblower reports say the companies used rebates to win Russian drug contracts, with single-participant bidding in about 95% of Tagrisso tenders.
6 Articles
6 Articles
Western Pharma Giants Paid Millions to Russian Distributors Linked to Fraud, Whistleblower Report Says
Four major Western pharmaceutical companies paid tens of millions of dollars in unusually high bonuses to Russian middlemen to supply cancer drugs to state hospitals, according to whistleblower documents submitted to U.S. financial regulators.
Western pharmaceutical companies spend up to $500 million a year on bribes in Russia — with Putin’s allies cashing in, Proekt investigation finds
Foreign pharmaceutical companies that supply cancer treatment drugs to Russia spend about $500 million a year on “bonuses” for intermediaries, suppliers, and staff at Russian hospitals, according to an investigation by Proekt, a Russian investigative outlet. The investigation is based on the testimony of a senior executive at an international pharmaceutical company operating in the Russian market.
Russian Officials Steal Nearly $500 Million a Year From Cancer Drug Purchases
Russian officials, healthcare managers, and pharmaceutical distributors have built a corruption system that diverts hundreds of millions of dollars from state purchases of cancer and other expensive medicines, independent Russian investigative journalism outlet Proekt reported on November 2.
Four major pharmaceutical companies are at the center of an investigation that highlights abnormal payments to Russian intermediaries to ensure supplies of cancer drugs. Read more Anti-cancer drugs: overpayment to Russian distributors on News.it.
The main route of drug corruption is the secret "commercial bonus" of manufacturers who, through small regional firms, are turning into bribes, told the journalist Catherine Reznikova's Project.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
